Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)

Experience with Rifabutin-Containing Therapy in 500 Patients from the European Registry on <i>Helicobacter pylori</i> Management (Hp-EuReg)

Background: First-line <i>Helicobacter pylori</i> (<i>H. pylori</i>) treatments have been relatively well evaluated; however, it remains necessary to identify the most effective rescue treatments. Our aim was to assess the effectiveness and safety of <i>H. pylori</i&...

Full description

Bibliographic Details
Main Authors: Olga P. Nyssen, Dino Vaira, Ilaria Maria Saracino, Giulia Fiorini, María Caldas, Luis Bujanda, Rinaldo Pellicano, Alma Keco-Huerga, Manuel Pabón-Carrasco, Elida Oblitas Susanibar, Alfredo Di Leo, Giuseppe Losurdo, Ángeles Pérez-Aísa, Antonio Gasbarrini, Doron Boltin, Sinead Smith, Perminder Phull, Theodore Rokkas, Dominique Lamarque, Anna Cano-Català, Ignasi Puig, Francis Mégraud, Colm O’Morain, Javier P. Gisbert
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Journal of Clinical Medicine
Subjects:
<i>Helicobacter pylori</i>
<i>H. pylori</i>
rifabutin
treatment
eradication failure
culture
Online Access:https://www.mdpi.com/2077-0383/11/6/1658

Internet

https://www.mdpi.com/2077-0383/11/6/1658

Similar Items